Phase II study shows clinical improvement with daratumumab A team led by PD Dr. Tobias Alexander, head of the Translational Rheumatology program area at the…
Dr. Ping Shen from the Pitzer Laboratory for Osteoarthritis Research at the DRFZ has been awarded funding from the Klaus Tschira Boost Fund to research…
Despite improved inflammation control 50 % of patients with rheumatic disease suffer from persistent exhaustion or fatigue Many people with inflammatory rheumatic diseases suffer from…
New Leibniz Junior Research Group investigates allele-specific gene regulation in inflammation Dr. Felix Weiss from the DRFZ has been successful in the latest round of…
Microbiota fingerprint as the key to personalised medicine On 3 December 2025, Dr Lisa Budzinski, from the Schwiete Laboratory for Microbiota and Inflammation at the…